Company data
Ligand Pharmaceuticals Incorporated employees and revenue per employee
LGND · Biotechnology · $6.05B market cap
Ligand Pharmaceuticals Incorporated had 47 employees at the end of fiscal Dec 2025, down 30.9% from a year earlier. Revenue for the year was $268M, up 60.4% from a year earlier, or $5.70M per employee. Revenue held up or grew while headcount stayed flat or fell.
Employees
47
-30.9% YoY
Revenue
$268M
+60.4% YoY
Revenue / employee
$5.70M
Peer median $574K
Rank in industry
1 of 46
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 47 | $268M | $5.70M | -30.9% | +60.4% |
| Dec 2024 | 68 | $167M | $2.46M | +17.2% | +27.3% |
| Dec 2023 | 58 | $131M | $2.26M | -23.7% | -33.1% |
| Dec 2022 | 76 | $196M | $2.58M | -50.6% | -18.8% |
| Dec 2021 | 154 | $242M | $1.57M | -0.6% | +47.7% |
| Dec 2020 | 155 | $164M | $1.06M | +34.8% | +36.0% |
| Dec 2019 | 115 | $120M | $1.05M | -0.9% | -52.2% |
| Dec 2018 | 116 | $251M | $2.17M | +197.4% | +78.2% |
| Dec 2017 | 39 | $141M | $3.62M | +77.3% | +29.5% |
| Dec 2016 | 22 | $109M | $4.95M | — | — |
Open roles: we have not matched a verified job board for this company yet.
Ligand Pharmaceuticals Incorporated against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| LGND Ligand Pharmaceuticals Incorporated | 47 | $268M | $5.70M | Leaner |
| KRYS Krystal Biotech, Inc. | 295 | $389M | $1.32M | Efficient growth |
| TVTX Travere Therapeutics, Inc. | 497 | $491M | $987K | Efficient growth |
| BBIO BridgeBio Pharma, Inc. | 834 | $502M | $602K | Efficient growth |
| RYTM Rhythm Pharmaceuticals, Inc. | 414 | $190M | $458K | Hiring ahead |
| ADPT Adaptive Biotechnologies Corporation | 624 | $277M | $444K | Efficient growth |
| RCUS Arcus Biosciences, Inc. | 601 | $247M | $411K | Contracting |
| TWST Twist Bioscience Corporation | 979 | $377M | $385K | Efficient growth |
| IOVA Iovance Biotherapeutics, Inc. | 975 | $264M | $270K | Efficient growth |
Questions about Ligand Pharmaceuticals Incorporated
- How many employees does Ligand Pharmaceuticals Incorporated have?
- Ligand Pharmaceuticals Incorporated reported 47 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is down 30.9% from a year earlier.
- What is Ligand Pharmaceuticals Incorporated's revenue per employee?
- Ligand Pharmaceuticals Incorporated brought in $268M of revenue in fiscal Dec 2025, which is $5.70M per employee. That ranks 1 of 46 companies we track in Biotechnology, where the median is $574K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare LGND with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Ligand Pharmaceuticals Incorporated's annual reports (Form 10-K), latest filed February 27, 2026. This is data, not a recommendation to buy or sell LGND.